- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Nourish Lands $70M to Fight Chronic Disease with Nutrition Care | ||
| Do | Trial Data Shows 'IUD for Men' Is Effective for 2 Years | ||
| Do | Aiming for Earlier Intervention, Flagship Startup Etiome Emerges to Define 'Biostages' of Disease | ||
| Do | MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease? | ||
| Do | How Health Insurers Are Embracing Technology to Serve Real People | ||
| Do | Advancing Patient & Planet Health Through Proper Healthcare Waste Management | ||
| Do | The Top Surgical Instruments Needed for Extractions | ||
| Do | There's a Gap Between Healthcare Leaders' AI Confidence and Their Ability to Scale | ||
| Do | World Class Health Secures $10M for Global Centers of Excellence Network | ||
| Mi | Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics | ||
| Mi | Improving Patient Trust with Digital Communication | ||
| Mi | The 4 Best Places to Buy Affordable Spectrometers for Lab Use | ||
| Mi | How Leveraging Information for Action can Build a More Sustainable Healthcare System | ||
| Mi | Free Market Health Acquires Beeline Rx to Streamline Specialty Prior Auth | ||
| Di | Nursing Exodus Continues: 4 in 10 Plan to Leave by 2029 | ||
| Di | Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom | ||
| Di | Telehealth Fraud & Compliance: Preventing 'Pill Mills' While Ensuring Access to Care | ||
| Di | The Critical Role Of Regional Vaccine Manufacturing In The Next Global Pandemic | ||
| Mo | Aeroflow Health Unveils New Diabetes Management Program | ||
| Mo | AstraZeneca & Daiichi Sankyo's Enhertu Posts Positive Data as First-Line Breast Cancer Therapy | ||
| Mo | Medicare Advantage CEO: My baby is ugly…(video) | ||
| Mo | Clinician Adoption: How HealthTech Can Overcome Key Barriers | ||
| Mo | The Price is Wrong: We Need to Solve the Healthcare Insurance Transparency Crisis | ||
| Mo | What Are Health Systems' Strategic Priorities in 2025? | ||
| So | Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
